This study shows that while 90% of U.S. schools stock naloxone (an opioid overdose reversal medication), most restrict access and rarely train students to use it.
This study investigates combining osimertinib and gefitinib in advanced lung cancer with EGFR C797S mutation, showing modest benefits but highlighting tumor resistance and limited efficacy.
This study investigates how YAP and TAZ, key regulators of cell growth, drive opposing immune responses with TAZ promoting tumor growth and YAP being constrained by inflammatory monocytes.
Yale Medicine Magazine was originally established in the 1950s as the medical school's alumni bulletin. Its articles cover discoveries in biomedicine, clinical advances, new ways of training tomorrow’s doctors, and the evolution of medicine and healthcare.